AI-generated summary
The authors reviewed 13 clinical studies on intravascular laser irradiation of blood (ILIB) used as an adjunct therapy for chronic systemic diseases, mostly coronary disease and type 2 diabetes. They report that all included studies showed satisfactory results in patients' clinical condition, though protocols varied. The authors note that research on this therapy remains scarce and that more well-designed clinical trials are needed.
- Studies included
- 13
- Who or what was studied
- Patients with chronic systemic diseases, most commonly coronary diseases, followed by type 2 diabetes mellitus
- Limits stated in the abstract
- The abstract states that studies on this therapy are still scarce and that more well-designed clinical trials are needed; protocols and parameters varied across studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.